Jovana Nikolic, MD

All articles by Jovana Nikolic, MD

• Ipsen-Genfit’s elafibranor shows promise in phase 3 PBC trial

  Treatment with elafibranor may improve bile flow in patients with primary biliary cholangitis (PBC), according to results of a phase 3 trial.

• Study: Deep learning could aid treatment of elderly adults with PBC

  A study shows deep learning can be used to guide treatment, predict ALBI scores, dose UDCA and prevent use of multiple drugs in elderly adults with PBC.

• Obeticholic acid may reduce the risk of negative outcomes in PBC

  Treatment of primary biliary cholangitis (PBC) with obeticholic acid may reduce negative outcomes in the disease, according to a study.

• Study shows high and variable prevalence of PBC in the US

  The prevalence of primary biliary cholangitis (PBC) in the U.S. may be high and variable between regions, according to a recent study.

• High blood fat in PBC may not affect blood vessels and liver health

  High blood levels of fats such as triglycerides and cholesterol in patients with PBC may not increase their risk for cardiovascular disease.